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INTRODUCTION
The best practice in pain control after craniotomy is 
debatable. Scalp block offers an advantage over systemic 
opioids because it does not obscure the assessment of 
neurological functions nor mask signs of neurological 
complications.[1] A previous meta-analysis published 
in 2013 reported limited benefits with low-quality 
evidence of scalp block compared to no-scalp block 
modalities for postcraniotomy analgesia.[2] However, 
they used mean differences for meta-analysis of 
studies using different pain intensity measurement 
scales: numeric rating scale (NRS) and visual analog 
scale (VAS). The outcomes measured using NRS were 
usually reported in median and interquartile range. 
Means and medians can be very different from each 
other if the data are skewed, and medians are often 
reported for skewed data. Thus, estimating means 
and standard deviations from reported medians and 
interquartile ranges could introduce bias to pooling. 
Therefore, we performed this meta-analysis of studies 
that used VAS for documenting pain intensity to 
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ABSTRACT
Background and Aims: A  previous meta-analysis reported that scalp block had limited 
benefits (low‑quality evidence) compared to no‑scalp block modalities for analgesia after craniotomy. 
However, it included studies using two different pain intensity measurement scales. Therefore, we 
performed another meta-analysis using a single scale. Methods: We conducted the search for all 
randomised controlled trials evaluating the effect of scalp block on postcraniotomy pain compared 
to no‑scalp block in Cochrane Central Register of Controlled Trials and PubMed database. We 
assessed the quality of included studies employing GRADE approach. We performed random‑effects 
inverse-variance weighted meta-analysis of outcomes including pain intensity assessed by a 0--10 
visual analog scale and opioid consumption during the first 24 h postoperative period using RevMan 
5.3. Results: A total of 10 studies (551 patients) were included. It revealed a statistically significant 
mean pain intensity reduction in scalp block group when compared to no-scalp block at very early 
and early 24 h period (seven trials, very low‑quality evidence, mean difference (MD) = −1.37, 95% 
confidence interval (CI): −2.23 to ‑0.05, I2 = 70%; nine trials, very low‑quality evidence, MD = −1.16, 
95% CI: −2.09 to −0.24, I2 = 57%, respectively). There was also reduction in the opioid requirements 
over the first 24 h postoperatively. Conclusion: Scalp block might be useful at <6 h postcraniotomy 
with very-low quality evidence. Additionally, it had uncertain but moderate effect on reducing total 
24 h opioid consumption. Therefore, more studies are needed to reach optimal information size.
Key words: Analgesia, craniotomy, pain, postsurgery, scalp block




How to cite this article: Wardhana A, Sudadi S. Scalp block for 
analgesia after craniotomy: A  meta‑analysis. Indian J Anaesth 
2019;63:886-94.
This is an open access journal, and articles are distributed under the terms of 
the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, 
which allows others to remix, tweak, and build upon the work non-commercially, 
as long as appropriate credit is given and the new creations are licensed under 
the identical terms.
For reprints contact: reprints@medknow.com
Page no. 20
Wardhana and Sudadi: Scalp block for analgesia after craniotomy
887Indian Journal of Anaesthesia | Volume 63 | Issue 11 | November 2019
Systematic Reviews and Meta-Analyses).[3] We selected 
randomised controlled trials (RCTs) that assessed either 
pain intensity with VAS or 24 h opioid consumption 
as primary or secondary outcomes. These studies 
compared pre- or postoperative scalp block to no-scalp 
block or placebo in adults undergoing craniotomy. 
No-scalp block included placebo or any analgesia 
modalities other than scalp block. We excluded 
studies that only examined the efficacy of local 
anaesthetic infiltration along a planned scalp incision 
(or postoperatively into the wound margin). Any study 
that had scalp block in all arms (i.e., studying adjuvant 
for scalp block regimen or comparing different doses 
or types of local anaesthetic) was also excluded.
We conducted the search using keywords of “scalp 
block” and “craniotomy” in the CENTRAL (Cochrane 
Central Register of Controlled Trials) database. The 
PubMed database was searched using a combination of 
medical subject headings (MeSH) terms (“craniotomy” 
or “neurosurgery”) and keyword (“scalp block”). 
We identified additional records through references 
of the included articles. We performed searching 
without language restriction on January 15, 2019. Two 
investigators (AW and SU) independently screened 
and assessed titles and abstracts before full-text 
retrieval. Then, the full papers that potentially met 
the inclusion/exclusion criteria were reviewed by two 
authors (AW and SU) for final inclusion.
Data extraction
Two investigators (AW and SU) extracted data, 
which included author, year of publication, 
number of patients, postcraniotomy pain treatment 
modality (timing and the dosage), pain intensity for 
all time points at which it was measured, total opioid 
consumption for 24 h, postoperative rescue analgesia. 
We recorded them using a dedicated data extraction 
form on an Excel spreadsheet.
The primary outcome was pain intensity assessed 
via VAS and total opioid consumption within 24 h 
postoperative period. We performed two comparisons 
including scalp block vs. no-scalp block and scalp 
block vs. placebo. We rescaled the interval of 0 to 100 
pain intensity of VAS to a standard interval of 0 to 
10. Pain intensity measurement was categorised into 
five	periods	(very	early:	≥0.5	h	but	<2	h;	early:	≥2	h	
but	<6	h;	 intermediate:	≥6	h	 but	 12	h;	 late:	≥12	h	
but	<20	h;	very	 late:	≥20	h	but	≤24	h.	When	 there	
were multiple intervention groups, each of all relevant 
experimental intervention groups of the study or 
each of all relevant control intervention groups were 
combined into a single group and the average of their 
mean and standard deviation were calculated using 
the formula in Table 7.7.a of the Cochrane Handbook.[4] 
We combined the data in a similar manner when there 
was more than one measured pain intensity of each 
study in one defined period.
We contacted corresponding authors to obtain any 
incomplete data. If the results were presented only in 
graphical form and there was no further information 
from the corresponding authors, the relevant data were 
extracted using ImageJ (ImageJ v1.52k January 2019: 
http://wsr.imagej.net/distros/win/ij152-win-java8.
zip). Two independent authors graded each included 
study for methodological quality by assessing risk of 
bias using the Cochrane Collaboration Risk of Bias 
Tool and employed the GRADE approach to assess 
the overall quality of the evidence.[5,6]
Data analysis
We conducted the meta-analysis using mean 
difference (MD) for pain intensity, whereas standard 
mean difference (SMD) was used for 24 h total opioid 
consumption. SMD was chosen because the specific 
opioid and route of administration varied among 
trials, and calculation of morphine equivalents may 
have introduced bias. We employed a random-effects 
and inverse-variance weighting using Review 
Manager (RevMan v5.3 2014). We conducted subgroup 
analysis based on timing of scalp block performed (pre- or 
postoperative). We evaluated between and within-study 
heterogeneity using the I2 statistic.
RESULTS
Search results and description of included trials
We identified a total of 48 studies from the CENTRAL 
database, 51 studies from PUBMED database, and 
7 studies from other sources as shown in Figure 1. 
A total of 14 duplicated studies and 46 non-RCTs 
studies were excluded following screening of 
titles and abstracts. Thirty-three other studies 
were excluded because of no any pain intensity 
outcome (13 studies), no suitable nonscalp block in 
control group (9), no relevant intervention (6), using 
NRS for the pain intensity measurement (4), and not 
craniotomy procedure (1 study). A study reporting 
24 h opioid consumption without the relevant pain 
intensity was also included.[7] Later, we excluded three 
studies because there was not sufficient information 
in the abstract and no email nor response from the 
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author/contacted corresponding author. However, 
we did not exclude two other in-abstract studies 
because they reported sufficient data to allow 
assessment of outcome.[8,9] Totally, we included only 
10 studies (551 patients) in the analysis.
Details of the included trials are displayed in Table 1. 
Two of their data[8,10] were extracted using ImageJ 
and two studies had missing data in some period of 
measurement.[9,11] Because our attempts to obtain 
further data from the corresponding authors failed, 
we performed sensitivity analysis based on removing 
those studies.
Nine studies[8-16] were analysed for pain intensity 
outcome and seven trials[7,8,10,12,13,15,16] for 24 h total 
opioid consumption outcome. The largest of the trials 
involved 90 patients.[11] Six studies included fewer 
than 50 patients. Four trials had three-arm design.[9-12] 
Data from systemic analgesia or scalp infiltration were 
combined with placebo into single no-scalp block 
group. However, they were excluded when comparing 
scalp block to placebo.[9] Data from scalp block using 
various agents were treated as single treatment 
group.[11,12] There were various opioids administered 
postoperatively including morphine, codeine, 
hydromorphone, and tramadol. Three trials used 
patient-controlled analgesia (PCA) device,[8,10,12] while 
the others administered rescue opioid as requested by 
patient or defined by high VAS.[7,13,15,16]
Methodological quality assessment
Two in-abstract studies were considered as high risk 
for all aspects of risk of bias assessment because risk 
of bias could not be ascertained. All trials did not 
report details of their randomisation strategy. One trial 
had different numbers of participants in each group 
suggesting a randomisation bias as shown in Figure 2.[13] 
Three trials had high risk of adhering-to-intervention 
bias because of no blinding to the anaesthesiologist 
who performed the intervention.[13-15] Measurement 
bias was suggested in five trials because there were no 
blinding to assessor.[11-13,15,16]
We downgraded a starting rating of ‘high-quality’ 
evidence by one level for serious concerns about risk 
of bias, inconsistency, indirectness, imprecision, or 
publication bias. We considered there was serious 
risk of bias in the included trials for every outcome. 
Outcomes with low heterogeneity (I2 <40%) 
suggested no inconsistency issue, while outcomes 
with substantial heterogeneity (I2 >60%) had 
severe inconsistency issue. We considered that the 
imprecision was present if the outcomes had less than 
400 participants in our meta-analysis.[6] We considered 
there was a publication bias because our results 
Figure 1: Study flow chart (as per PRISMA guideline) Figure 2: Risk of bias assessment summary
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Table 1: Included trials
Author Year Timing Scalp block Volume 
(ml)








2008 Preoperative 0.5% 
ropivacaine 





2009 Postoperative 0.75% 
ropivacaine
16 Placebo 16 0.5, 1, 2, 4, 6, 






2016 Preoperative 0.5% 
bupivacaine/2% 
lidocaine










2001 Postoperative 0.75% 
ropivacaine
20 20 Placebo 20 4, 8, 12, 16, 20, 






















2017 Preoperative 0.5% 
bupivacaine
20 15 Scalp 
infiltration 0.5% 
bupivacaine
15 10 m, 1, 2, 6, 
12, and 24 h
VAS 
1‑10




2017 Preoperative 0.5% 
bupivacaine









































25 1, 3, 6, and 24 h
Ayoub 
et al.[7]
2006 Post‑operative 0.5% 
bupivacaine/2% 
lidocaine








came from small study populations. Funnel plots 
also showed an asymmetrical appearance indicating 
publication bias [Figure 3]. We did not conduct test for 
funnel plot asymmetry because there were less than 
ten included studies.[4] We understand that there was 
indication of publication bias. However, there was no 
diversity in the comparisons being made by the primary 
studies. Therefore, we considered that we can derive 
meaningful conclusions from our meta-analysis. To 
know the quality of evidence, we performed GRADE 
evaluation. Based on GRADE evaluation in Table 2, we 
determined that the evidences for each outcome were 
at most low quality.
Pain intensity at the very early 24 h period
Random-effects meta-analysis revealed a mean pain 
intensity reduction in patients receiving scalp block 
when compared to no-scalp block (seven trials) and 
placebo (five trials) at the very early 24 h period as 
shown in Figure	 4	 (mean	 difference	 (MD)	=	−1.37,	
95%	 confidence	 interval	 (CI):	 −2.23	 to	 −0.05,	
I2	=	70%,	and	MD	=	−1.39,	95%	CI:	−2.88	 to	0.11,	
I2 = 87%, respectively) as shown in Table 3. We 
detected substantial statistical heterogeneity. However, 
when including only the trials with placebo as control, 
the heterogeneity increased. Sensitivity analysis in 
group comparison to no-scalp block showed a mean 
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difference	 of	−0.61	with	 95%	CI	−1.34	 to	 0.13	 and	
I2 = 0%.
Pain intensity at the early 24 h period
At early 24 h period postcraniotomy, scalp block 
was more effective than no-scalp block (MD of 
pain	intensity	score	−1.16,	95%	CI	−2.09	to	−0.24,	
I2 = 57%, nine trials) and placebo (MD of pain intensity 
score	 −1.33,	 95%	 CI	 −2.53	 to	 −0.13,	 I2 = 74%, 
nine trials) as shown in Figure 4. The heterogeneity 
increased even though we included only trials with 
placebo as control. Sensitivity analysis in group 
comparison to no-scalp block showed a mean 
difference	of	−0.76	with	95%	CI	−1.64	 to	0.13	and	
I2 = 10%.
Pain intensity at the intermediate 24 h period
Random-effects meta-analysis showed that scalp 
block reduced mean pain intensity at intermediate 
24 h period when compared to no-scalp block 
(seven trials) and placebo (six trials) as shown in 
Figure	 4	 (MD	 =	 −0.44,	 95%	 CI:	 −1.03	 to	 −0.15,	
Table 2: GRADE assessment results
Comparison Outcomes Risk of bias Inconsistency Indirectness Imprecision Publication of bias GRADE
Vs. no‑scalp block Very Early Serious Severe No at all No Presence Very low
Early Serious Some No at all Some Presence Very Low
Intermediate Serious Some No at all No Presence Low
Late Serious No No at all No Presence Low
Very Late Serious Some No at all No Presence Very Low
Vs. placebo Very Early Serious Severe No at all No Presence Very low
Early Serious No No at all No Presence Low
Intermediate Serious No No at all Some Presence Low
Late Serious No No at all Some Presence Low
Very Late Serious Some No at all Some Presence Very low
Vs. no‑scalp block Opioid consumption Serious Some No at all Some Presence Very low
Vs. placebo Opioid consumption Serious Severe No at all Some Presence Very low
Figure 3: Funnel plot of comparison Scalp block vs. no-scalp block, 
outcome at very early 24 h period postoperatively
Table 3: Summary of meta‑analysis result
Vs. no‑scalp block All studies I2 Preoperative I2 Postoperative I2
Subgroup n Effect size (95% CI) n Effect size (95% CI) n Effect size (95% CI)
Pain intensity after surgery
Very early period 7 (371) −1.37 [−2.23, −0.50] 70% 4 (175) −1.40 [−2.59, −0.21] 57% 3 (196) −1.27 [−2.72, 0.17] 76%
Early period 9 (501) −1.16 [−2.09, −0.24] 57% 5 (265) −1.11 [−2.36, 0.15] 63% 4 (236) −1.15 [−2.97, 0.66] 56%
Intermediate 7 (431) −0.44 [−1.03, 0.15] 43% 3 (195) −0.12 [−0.62, 0.37] 17% 4 (236) −1.03 [−1.77, −0.29] 0%
Late period 7 (396) −0.50 [−1.06, 007] 25% 4 (235) −0.43 [−0.71, −0.15] 0% 3 (161) −1.24 [−2.91, 0.43] 57%
Very late period 7 (431) −0.54 [−1.37, 0.29] 77% 3 (195) −0.50 [−1.79, 0.78] 78% 4 (236) −0.62 [−1.94, 0.70] 77%
24 h total opioid 
consumption
7 (346) −0.36 [−0.76, 0.04] 68% 3 (135) −0.61 [−1.24, 0.01] 65% 4 (211) −0.18 [−0.67, 0.31] 66%
Vs. placebo All studies I2 Preoperative I2 Postoperative I2
Subgroup n Effect size (95% CI) n Effect size (95% CI) n Effect size (95% CI)
Pain intensity after surgery
Very early period 5 (241) −1.39 [−2.88, 0.11] 87% 3 (120) −1.73 [−3.37, −0.09] 76% 2 (121) −0.56 [−1.50, 0.38] NA
Early period 7 (371) −1.33 [−2.53, −0.13] 74% 4 (210) −1.38 [−3.12, 0.35] 80% 3 (161) −1.15 [−2.97, 0.66] 56%
Intermediate 6 (341) −0.09 [−0.61, 0.44] 14% 3 (180) 0.06 [−0.39, 0.51] 0% 3 (161) −0.77 [−1.86, 0.33] 1%
Late period 6 (341) −0.53 [−1.23, 0.17] 39% 3 (180) −0.33 [−0.78, 0.12] 0% 3 (161) −1.24 [−2.91, 0.43] 57%
Very late period 6 (341) −0.22 [−1.01, 0.56] 67% 3 (180) −0.37 [−1.35, 0.60] 60% 3 (161) −0.19 [−1.47, 1.10] 67%
24 h total opioid 
consumption
6 (281) −0.53 [−1.07, 0.02] 78% 3 (120) −0.80 [−1.74, 0.14] 81% 3 (161) −0.28 [−0.98, 0.42] 77%
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I2	=	43%,	and	MD	=	−0.09,	95%	CI:	−0.61	to	0.44,	
I2 = 14%, respectively). Sensitivity analysis in 
group comparison to no-scalp block showed a mean 
difference	of	−0.27	with	95%	CI	−1.35	to	0.81	and	
I2 = 38%.
Pain intensity at the late 24 h period
Patients in scalp block group at late 24 h period reported a 
pooled lower mean difference as shown in Figure 4 (MD 
=	−0.50,	 95%	CI:	−1.06	 to	 0.07,	 I2 = 25%, and MD 
=	−0.54,	 95%	 CI:	 −1.37	 to	 0.29,	 I2 = 77%) in pain 
Figure 4: Forest plot of pain intensity outcome
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intensity than in the no-scalp block group and placebo 
group, respectively. There was substantial statistical 
heterogeneity in comparison between scalp block and 
placebo. Sensitivity analysis in group comparison to 
no‑scalp	block	showed	a	mean	difference	of	−0.56	with	
95%	CI	−1.68	to	0.56	and	I2 = 44%.
Pain intensity at the very late 24 h period
Scalp	block	has	some	effect	(MD	=	−0.54)	on	reducing	
pain	intensity	with	95%	confidence	of	−1.37	to	0.29	
compared	 to	no‑scalp	block	 and	effect	 of	MD	−0.22	
with	 95%	 confidence	 of	−1.01	 to	 0.56	 compared	 to	
placebo at very late 24 h period as shown in Figure 4. 
There was substantial statistical heterogeneity. 
Sensitivity analysis in group comparison to no-scalp 
block	 showed	a	mean	difference	of	−0.37	with	95%	
CI	−1.22	to	0.49	and	I2 = 12%.
Opioid consumption within 24 h period
Administration of scalp block reduced total opioid 
consumption within 24 h when compared to no-scalp 
block and placebo in a random-effects meta-analysis as 
shown in Figure	5	(SMD	=	−0.36	with	95%	CI	−0.76	
to 0.04, I2	 =	 68%	 and	 SMD	 =	 −0.53	 with	 95%	
CI	−1.07	 to	 0.02,	 I2 = 78%, respectively). However, 
there were no statistically significant differences. 
There was evidence of substantial heterogeneity in 
both comparisons.
DISCUSSION
Meta-analysis was performed separately for pain 
intensity assessed at very early, early, intermediate, late, 
and very late 24 h postoperative periods. Our analysis 
favored the scalp block at all periods compared to either 
no-scalp block or placebo, although we were certain 
the results only at up to the 6 h postoperative period. 
However, the results were graded as very low-quality 
evidence based on GRADE approach. In subgroup 
analysis, meta-analysis favored the preoperative scalp 
block group more than the no-scalp block group at the 
very early and late periods. Postoperative scalp block 
group had certain pain intensity reduction only at the 
intermediate period.
There was significant heterogeneity in the treatment 
effect at all periods except the intermediate and late 
period assessment. The sensitivity analysis showed 
improvement in heterogeneity. The sensitivity 
analysis demonstrated no significant difference in 
both comparisons at all periods. This suggested that 
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scalp block at up to the 6 h postoperative period could 
be affected by the decision to include trials which had 
incomplete data.
A systematic review by Tsaousi et al.[17] put scalp 
infiltration and scalp block into one category and the 
conclusion of beneficial scalp infiltration/block in 
the early postoperative pain management came from 
only one scalp infiltration trial,[18] not from the two 
included scalp block trials.[14,19] Another systematic 
review by Akhigbe and Zolnourian[20] involving five 
trials[7,12,15,19,21] concluded that scalp block provided 
analgesia after craniotomy. However, the authors 
mentioned that the evidence was limited because most 
data were confounded by weaknesses in methodology 
and most of the studies have small sample sizes.
Previous meta-analysis combining trials using NRS 
and VAS reported significant reduction in pain 
intensity up to 6--8 h postoperatively, however, with 
high heterogeneity.[2] Our study included only studies 
measuring pain score in VAS, but not NRS. We 
excluded trials using NRS because SMD may be used 
in meta-analysis for combining continuous data only, 
not ordinal one.[22]
Sise of the effect in pain intensity was around only 
1-point. It probably indicates little to no implication in 
practice. However, scalp block had moderate effect in 
reducing 24 h total opioid consumption which reflects 
more a quantitative, not self-reporting outcome.
Included studies are insufficient to address the 
objective because their quality at most is graded as low. 
Wide confidence interval in our meta-analysis was due 
to increased heterogeneity because our analysis used 
random-effects models. Variation in local anaesthetic 
or postoperatively opioid management and timing 
may contribute to the wide CI.
There were some limitations in this meta-analysis. 
First, we searched studies only in two databases. 
Second, we included four trials whose data were 
incomplete. Removal of those studies from further 
meta-analysis made differences in estimates of effect 
for pain intensity reduction. This finding may generate 
for further research.
CONCLUSION
We conclude that the scalp block might be useful at 
the earliest period (<6 hour postcraniotomy) with 
very low-quality evidence and substantial statistical 
heterogeneity from nine trials. In addition, scalp 
block had uncertain but moderate effect on reducing 
total 24 h opioid consumption compared to no-scalp 
block. Therefore, more studies are needed with more 
participants to reach optimal information size for 
benefit assessment of scalp block.
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“ANAESTHESIA A COMPLETE SPECIALITY‑ WE ARE THE LIFELINE” 
AND OUR LIFELINE IS 
“ISA FAMILY BENEVOLENT FUND”
•	 	ISA	encourages	members	to	join	Family	Benevolent	Fund	of	Indian	Society	of	Anaesthesiologists	
(ISA-FBF) to help our colleagues’ and our own families when they face the testing moments of their 
life.
•	 	BECOME	AN	ISAFBF	MEMBER,	NOT	FOR	YOU,	BUT	TO	HELP	OUR	COLLEAGUE’S	FAMILIES	BY	
DONATING Rs.300/- per year /death.
•	 	TO	BECOME	AN	ISAFBF	MEMBER	KINDLY	VISIT	OUR	WEBSITE	isafbf.com	or	CONTACT	YOUR	
CITY BRANCH/STATE/PRESIDENT/SECRETARY
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 Mobile: +91-9447052094
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